.

Deeper Knowledge, Faster

  • Plan your formulary budget
  • Uncover prior art in expired and abandoned patents
  • Drug patents in 130+ countries

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Fish and Richardson
Colorcon
Cantor Fitzgerald
US Department of Justice
UBS
Boehringer Ingelheim
McKesson
Merck
QuintilesIMS
Harvard Business School

Generated: July 25, 2017

DrugPatentWatch Database Preview

Claims for Patent: ► Subscribe

« Back to Dashboard

Claims for Patent: ► Subscribe

Title: Sustained delivery of an active agent using an implantable system
Abstract:The invention is directed to a device for delivering an active agent formulation for a predetermined administration period. An impermeable reservoir is divided into a water-swellable agent chamber and an active agent formulation chamber. Fluid from the environment is imbibed through a semipermeable plug into the water-swellable agent chamber and the active agent formulation is released through a back-diffusion regulating outlet. Delivery periods of up to 2 years are achieved.
Inventor(s): Peery; John R. (Stanford, CA), Dionne; Keith E. (Menlo Park, CA), Eckenhoff, deceased; James B. (late of Los Altos, CA), Landrau; Felix A. (Punta Gorda, FL), Lautenbach; Scott D. (San Mateo, CA), Magruder; Judy A (Mountain View, CA), Wright; Jeremy C. (Los Altos, CA)
Assignee: ALZA Corporation (Mountain View, CA)
Application Number:09/310,149
Patent Claims: 1. A fluid-imbibing device for delivering an active agent to a fluid environment of use, said device comprising a water-swellable semipermeable material in the form of a plug that is received in sealing relationship with the interior surface of one end of an impermeable reservoir and an active agent to be displaced from the device when the water swellable material swells, wherein the semipermeable material is assembled into an open end of the reservoir.

2. The device of claim 1 wherein the semipermeable material is selected from the group consisting of plasticized cellulosic materials, polyurethanes and polyamides.

3. The device of claim 1 wherein the aspect ratio of the plug is 1:10 to 10:1 length to diameter.

4. A fluid-imbibing device for delivering an active agent to a fluid environment of use, said device comprising a water-swellable semipermeable material in the form of a plug that is received in sealing relationship with the interior surface of one end of an impermeable reservoir and an active agent to be displaced from the device when the water swellable material swells, wherein the semipermeable material is assembled into a cavity in said reservoir.

5. The device of claim 4 wherein the cavity is of a shape selected from the group consisting of a cylindrical, stepped, helical threaded and spaced configuration.

6. The device of claim 1 wherein the active agent is selected from the group consisting of a protein, a peptide or a gene therapy agent.

7. The device of claim 6 wherein the active agent is an LHRH agonist or antagonist.

8. The device of claim 6 wherein the active agent is leuprolide.

9. The device of claim 6 wherein the active agent is selected from the group consisting of Factor VIII and Factor IX.

10. The device of claim 1 wherein the active agent is delivered to a site remote from the device.

11. A semipermeable plug useful in an active agent delivery system for delivering active agent to a fluid environment of use, wherein said system comprises an impermeable reservoir, said plug being water-swellable and expanding linearly in said delivery system to commence pumping of active agent upon insertion of the delivery system in the fluid environment of use, wherein the semipermeable plug is assembled into an open end of said reservoir.
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Healthtrust
Chinese Patent Office
Medtronic
Express Scripts
Chubb
Teva
Merck
Queensland Health
Moodys
McKinsey

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot